The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...
Real-world cardiac evaluation in patients with advanced lung cancer who received immune checkpoint inhibitors. Anlotinib in combination with epirubicin followed by maintenance anlotinib versus placebo ...
Patient-reported outcomes (PROs), which assess symptoms, functional status, and quality of life, had independent prognostic value for overall survival in patients with cancer, according to a ...
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results Patients diagnosed with hereditary RC are more prone to ...
Please provide your email address to receive an email when new articles are posted on . Use of an electronic patient-reported outcome-based program did not significantly reduce ED or inpatient visits ...
The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just announced the publication of its pivotal paper in The ...
Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
A large multinational clinical trial has found that giving healthcare providers access to European Organisation for Research and Treatment of Cancer (EORTC) patient-reported outcome (PRO) data ...
Morning Overview on MSN
Personalized mRNA vaccine for pancreatic cancer shows survivors alive 6 years later
Pancreatic cancer kills roughly nine out of every ten people diagnosed with it, most within five years. So when researchers ...
Please provide your email address to receive an email when new articles are posted on . Patient-reported physical function predicts which patients gain greatest survival benefit from daratumumab.
Cancer care discrimination affects transgender and non-binary patients and is linked to poorer health. Learn more about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results